Hepatocyte nuclear factor-1α is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers

Drug Metabolism and Disposition

Volumn 30, Issue 6, 2002, Pages 613-615

  Toide, Kenji ^a   Takahashi, Yoshiki ^a   Yamazaki, Hiroshi ^a   Terauchi, Yoshiaki ^b   Fujii, Toshihiko ^b   Parkinson, Andrew ^c   Kamataki, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GENE PRODUCT; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 2B7; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; MESSENGER RNA; NUCLEAR FACTOR I; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

DNA-BINDING PROTEINS; GLUCURONOSYLTRANSFERASE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; ISOENZYMES; LIVER; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0036266930     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.6.613     Document Type: Article

References (23)

1. 3′-azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7)
2. Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1
3. Bilirubin UDP-glucuronosyltransferase I is the only relevant bilirubin glucuronidating isoform in man
4. Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases
5. Thermostabilization and thermoactivation of thermolabile enzymes by trehalose and its application for the synthesis of full length cDNA
6. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268)
7. Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers
8. Tissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoter
9. HNF1 alpha activates the rat UDP glucuronosyltransferase UGT2B1 gene promoter
10. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter
11. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs
12. Polymorphisms in UDP glucuronosyl-transferase genes: Functional consequences and clinical relevance
13. The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence
14. Involvement of hepatocyte nuclear factor 1 in the regulation of the UDP-glucuronosyltransferase 1A7 (UGT1A7) gene in rat hepatocytes
15. Zidovudine glucuronidation in human liver: Interindividual variability
16. (S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7
17. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity
18. Hepatocyte nuclear factor I inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome
19. Human UDP-glucuronosyltransferase 2B7
20. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4
21. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease
22. Extrahepatic expression of NAD(P)H: Menadione oxidoreductase, UDP glucuronosyltransferase-1A6, microsomal aldehyde dehydrogenase, and hepatic nuclear factor-1 alpha mRNAs in ch/ch and 14CoS/14CoS mice
23. Human drug-metabolizing enzyme variants